MGMT and glioblastoma: TMZ is the most commonly used drug in GBM treatment due to its good blood–brain barrier penetration and generally mild toxicity (Stupp et al., 2005), and MGMT promoter methylation status is predictive for the treatment response to TMZ (Malmstrom et al., 2012).